Jitendra Sriram, MD & Head of Research at HSBC India is neutral on Infosys.
Jitendra Sriram, MD & Head of Research at HSBC India told CNBC-TV18, "We are still neutral on Infosys . To a large degree, I would think that any kind of restructuring or reshaping of policies or strategy for any company will take time. It is not a magic wand that changes overnight. It is going to be a little bit of a painful process, so it will take its own sweet time to come about and show benefits."
At 11:18 hrs Infosys was quoting at Rs 2,438.50, up Rs 17.05, or 0.70 percent. It has touched an intraday high of Rs 2,443.15 and an intraday low of Rs 2,426.60.
The company's trailing 12-month (TTM) EPS was at Rs 129.58 per share. (Mar, 2013). The stock's price-to-earnings (P/E) ratio was 18.85. The latest book value of the company is Rs 627.95 per share. At current value, the price-to-book value of the company was 3.89. The dividend yield of the company was 1.72 percent.
Set email alert for
ADS BY GOOGLE
video of the day
Don’t try to time market; OMCs, paint cos to benefit: Emkay